(Q69319498)
Statements
In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic (English)
Ramos EL
Leggat JE
Milford EL
Kirkman RL
Tilney NL
Strom TB
Shapiro ME
Waldmann TA
1 January 1989